Mycoplasma Detection Systems Industry Registered A Y-O-Y Increase Worth 7.1% From 2022 To 2032

Healthcare

Mycoplasma detection is gaining significant traction in the biopharmaceuticals industry. Biopharmaceuticals represent around one-fourth share of total pharmaceutical industry revenue generation which is growing year on year by a substantial rate.

The superior efficacy of biopharmaceuticals in treating chronic diseases is making them the choice of treatment which in turn is increasing biopharmaceutical production. Mycoplasma is the most common contaminant in the biopharmaceuticals industry, therefore mycoplasma detection devices are gaining significant adoption to ensure biopharmaceuticals product safety.

Request Sample

Competitive Landscape

Prominent Mycoplasma detection systems providers are reliant on partnerships, collaborations, acquisitions, and new software launches so as to stay afloat in the global market. Constant innovations to ensure a seamless client-customer relationship are the main focus of prominent market players.

  • In June 2021, Agilent Technologies Inc. announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software in addition to Agilent’s portfolio of automated pathology staining solutions.
  • In Nov 2021, Merck KGaA, a leading science and technology company, announced the completion of its $17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.

Key Segments Covered in the Mycoplasma Detection Systems Industry Survey

  • Mycoplasma detection systems by Product Type

    • Mycoplasma detection systems Kits and Reagents
      • Nucleic Acid Detection Kits
      • PCR Assays
      • Elimination Kits & Reagents
      • Others
    • Mycoplasma Detection Services
    • Mycoplasma Detection Systems
      • PCR Based Systems
      • Luminescence Based Systems
  • Mycoplasma Detection Systems by Technique

    • PCR Mycoplasma detection systems
    • ELISA Mycoplasma detection systems
    • Direct & Indirect Assay Mycoplasma detection systems
    • Others
  • Mycoplasma Detection Systems by End User

    • Mycoplasma Detection Systems in Pharmaceutical & Biopharmaceutical Companies
    • Mycoplasma detection systems in Research Laboratories
    • Mycoplasma detection systems in Contract Research Organizations (CROs)
    • Mycoplasma detection systems in Academic Research Institutes
  • Mycoplasma Detection Systems by Region

    • North America Mycoplasma Detection Systems Market
    • Latin America Mycoplasma Detection Systems Market
    • Europe Mycoplasma Detection Systems Market
    • Asia Pacific Mycoplasma Detection Systems Market
    • Middle East & Africa Mycoplasma Detection Systems Market

Leave a Reply

Related Posts